ARTICLE | Clinical News

Taxotere docetaxel regulatory update

March 27, 2006 8:00 AM UTC

FDA approved an sNDA for Taxotere injection concentrate in combination with cisplatin and 5-fluorouracil (5-FU) to treat advanced gastric cancer, including gastroesophageal junction cancer, in patients with no prior chemotherapy. The sNDA had priority review designation. The microtubule-stabilizing taxoid already is approved to treat various cancers. ...